Portal Innovations

Portal Innovations is a Chicago-based venture development engine that specializes in supporting early-stage life sciences, medtech, and bioinformatics startups. Founded by John Flavin, a seasoned entrepreneur with a strong track record in life sciences, Portal Innovations provides what it calls "Crafted Capital™," which includes seed funding, state-of-the-art lab space, and strategic management support. The firm operates in key U.S. biotech hubs, including Chicago, Atlanta, Boston, and Houston, offering over 80,000 square feet of lab and office space tailored to the needs of its portfolio companies. Portal Innovations has a unique approach that bridges scientific ideation through commercial proof of concept by leveraging strong ties with academic institutions and industry partners. This enables them to identify and nurture promising startups, particularly those emerging from university labs. Portal Innovations' portfolio includes a diverse range of companies such as Cardiosense, which is developing a digital biomarker platform, and ClostraBio, focused on new therapeutics for inflammatory bowel disease and food allergies. The firm’s recent expansion into Houston, in collaboration with the Texas Medical Center, highlights its commitment to growing the U.S. life sciences ecosystem by providing critical resources and support to early-stage companies​.